Antibodies to humanized nerve growth factor(Shenyang Sunshine Pharmaceutical)

人源化神经生长因子抗体(沈阳三生制药)

Report date: 2026/05/13 20:02:10

Base Information

Drug NameAntibodies to humanized nerve growth factor(Shenyang Sunshine Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Nerve growth factor
TargetsNerve growth factor
Therapy Area/IndicationsBone metastasesCancer PainBone Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsBone metastasesCancer PainBone Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A